Asthma Clinical Trials in Basel
2 recruitingBasel, Switzerland
Showing 1–2 of 2 trials
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
Swiss Paediatric Airway Cohort
AsthmaWheezingCough+3 more
University of Bern6,000 enrolled12 locationsNCT03505216